Skip to content

Author

Yu-Hang Wang

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

Intratumoral heterogeneity as a potential biomarker for immunotherapy response and postoperative recurrence in NSCLC

Background Intratumoral heterogeneity (ITH) is associated with poor prognosis in various solid tumors. However, its use as a predictive biomarker for immunotherapy in advanced non-small cell lung cancer (NSCLC) is still lacking. Methods We used Maftools to analyze somatic variants of NSCLC from independent cohorts (POP...

Yu-Hang Wang, Xiaoying Dong, Yu-Cheng Yin et al. · 0 citations
Open access Aug 2026

Lactylation-related immune-metabolic dysregulation defines prognostic and therapeutic stratification in lung adenocarcinoma

Highlights • Single-cell analysis maps lactylation activity across the LUAD ecosystem.• Lactylation-high states show remodeled cell-cell communication networks.• A machine learning-derived LRPS predicts prognosis across cohorts.• Low LRPS is associated with greater immunotherapy benefit.• KRT7 promotes malignant LUAD p...

Meng Wang, Han Zhang, Qiuqiao Mu et al. · 1 citation

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.